Capital Performance Advisors »

Regeneron Pharmaceuticals shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $518k 671 771.87
2025-09-30 $355k 631 562.27
2024-09-30 $14k 13 1051.23

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Internatnal Val (DFIV)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Intl Small Cap V (DISV)

View all positions for Capital Performance Advisors

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Goldman Sachs Group
Nuveen
Northern Trust

View all funds holding Regeneron Pharmaceuticals